glp-1 stomach paralysis attorney in west virginia Patients Are Suing Over Alleged Side Effects of Weight-Loss Drugs GLP-1 Weight Loss Drugs and

& Pavi, I

A.Andrs-GuerreroV.Herrero-VanrellR.Bentez-Del-CastilloJ

Wegovy is given through a pen injection, under the skin weekly, and begins with a25 mg dose, per week for the initial four weeks before gradually increasing every four weeks until it reaches a goal of 2.4 mg per week as the maximum dosage

Incidences of hypothyroidism and autoimmune thyroiditis are increased in patients with nonalcoholic fatty liver disease

However, as with any cosmetic procedure, there are potential risks and side effects, including temporary swelling, bruising, redness, or tenderness at the injection sites

Makes weight loss attainable